Fri.Jan 31, 2025

article thumbnail

A long-awaited update on anxiety and antidepressants

STAT

Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds.  Sign up here. Too much news to include below, but apparently we should all be scratching our itches.

233
233
article thumbnail

Pharma’s forecast for 2025: Sowing seeds of a rebound

PharmaVoice

Despite regulatory uncertainty, pharma is bouncing back from a market slump and is being fueled by innovation.

147
147
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

A new, non-opioid pain drug is here. Getting it to patients could be agony.

BioPharma Dive

After decades of research, Vertex Pharmaceuticals now has an approved pain medication. Can one of the world’s most powerful biotechs contend with a healthcare system that’s long favored opioids?

129
129
article thumbnail

FDA approves Vertex’s acute pain treatment Journavx

Pharmaceutical Technology

The FDA has approved Vertex Pharmaceuticals oral Journavx (suzetrigine) to treat adults with moderate-to-severe acute pain.

108
108
article thumbnail

Navigating Payroll Compliance: Future-Proofing Payroll in an Evolving Regulatory Landscape

Speaker: Jennifer Hill

Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.

article thumbnail

AstraZeneca abandons plan for £450m vaccine plant in UK

pharmaphorum

In a shock move, AstraZeneca has ditched its plan to invest 450m in a new vaccine manufacturing plant in the UK.

More Trending

article thumbnail

Two more biotechs, Metsera and Maze, cross IPO finish line

pharmaphorum

Metsera and Maze Therapeutics have become the second and third biotechs to complete an IPO on the Nasdaq this year.

95
article thumbnail

Roche targets continued growth after strong 2024 sales

Pharmaceutical Technology

Roche achieved a sales growth of 7% (3% in CHF) in 2024, citing strong demand for pharmaceutical products.

93
article thumbnail

Rad AI raises $60m, and other digital financings

pharmaphorum

Recent financings in the digital health and AI space include rounds for Rad AI, Eleos, Allara Health, Manas AI, Delfina Care, and Grey Matter Neuro

93
article thumbnail

Researchers identify genetic 'fingerprint' to predict drug resistance in bacteria

World Pharma News

Antibiotic resistance is a global public health crisis responsible for more than a million deaths annually. By 2050, the World Health Organization estimates it could surpass cancer and heart disease as the leading cause of death as more bacteria develop defenses to the drugs designed to combat them. Now Tulane University researchers have identified a unique genetic signature in bacteria that can predict their likelihood of developing antibiotic resistance, according to a new study published in N

article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Vertex bags FDA okay for its non-opioid pain drug

pharmaphorum

Vertex gets FDA approval for its non-opioid pain drug suzetrigine, the first new class of pain medicine in the US in more than 20 years.

80
article thumbnail

Regulations in AI and Other Digital Technologies

PharmaTech

AI regulations in healthcare are rapidly evolving, and one should consult with regulatory subject matter experts, says Siegfried Schmitt, PhD, vice president, Technical at Parexel.

64
article thumbnail

Rentschler closes UK cell and gene therapy facility and does a pivot to biologics 

Pharmaceutical Technology

The CDMO has not disclosed how many employees will be affected by the operational wind down.

59
article thumbnail

Novartis sets ‘ambitious’ target; Skyrizi, Rinvoq sales climb

BioPharma Dive

Novartis issued stronger guidance than Wall Street expected. Elsewhere, Eisai and Biogen’s Alzheimer’s drug will get a closer look in Europe and Daiichi Sankyo is switching CEOs.

59
article thumbnail

Why Every Small Business Needs an HCM Solution: A Comprehensive Guide

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

article thumbnail

FDA Approves Actemra Biosimilar

Pharmaceutical Commerce

Celltrions Avtozma has been indicated for the treatment of giant cell arteritis, polyarticular juvenile idiopathic arthritis, rheumatoid arthritis, systemic juvenile idiopathic arthritis, and COVID-19in the same dosages and formulations as its tocilizumab reference product.

article thumbnail

All change in Germany – confidential pricing in, IRP out

Pharmaceutical Technology

On 1 January 2025, important legal amendments relating to drug pricing in Germany included in the Medical Research Act came into legal force.

article thumbnail

ACG – Unlock regulatory insights with our on-demand webinar

Express Pharma

Looking to take your DPI products to the Asian market? Regulatory challenges neednt slow you down. Watch our on-demand webinar to gain the knowledge you need to develop and launch your DPI products with confidence, in a complex regulatory landscape. Understand market opportunities Explore the growing market for respiratory drug administration, and how to succeed.

59
article thumbnail

NHS England to offer Casgevy for sickle cell disease patients

Pharmaceutical Technology

CRISPR-based gene therapy Casgevy has been made available to patients with sickle cell disease in England.

59
article thumbnail

Best Practices to Streamline Compensation Management: A Foundation for Growth

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

article thumbnail

Why Pharmacists Are Leaving: Burnout, Low Pay & Unmet Expectations

The Happy PharmD

Pharmacists are at a breaking point. Once passionate about their careers, many are now feeling burnt out, overworked, and honestly, disillusioned. Its hard to ignore the signsempty shelves, frustrated staff, angry customers, and more pharmacists walking out the door every day. What happened to the job that many once loved? Pharmacists have become the healthcare systems punching bag.

article thumbnail

Top 20 biopharma companies’ market caps rise 1.7% over 2024 amid policy

Pharmaceutical Technology

The top 20 biopharmaceutical companies experienced mixed performance in 2024 amid a dynamic landscape influenced by various factors.

59
article thumbnail

Troy Tazbaz, an FDA digital health leader, resigns

BioPharma Dive

Tazbaz was director of the FDA’s Digital Health Center of Excellence for two years, leading on policies involving artificial intelligence and software as a medical device.

52
article thumbnail

Hiroyuki Okuzawa succeeds Sunao Manabe as Daiichi Sankyo CEO

Pharmaceutical Technology

Daiichi Sankyo has announced that Hiroyuki Okuzawa will succeed Sunao Manabe as chief executive officer from 1 April 2025.

59
article thumbnail

Enhance Healthcare Efficiency With Top Payroll & HCM Services

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

article thumbnail

Dealmaking on the Rise?

PharmaTech

If the conditions prove optimal, 2025 could be a prosperous year for bio/pharma business deals.

52
article thumbnail

FDA Approves Axsome Therapeutics’ Symbravo for Migraine with or without Aura

PharmExec

Clinical trials demonstrated that a single dose of Symbravo provides rapid migraine relief, sustains efficacy for up to 48 hours, and reduces the need for rescue medication.

52
article thumbnail

JP Morgan Week 2025 – Steve Pakola

pharmaphorum

Watch the exclusive interview with Steve Pakola during the JP Morgan Week 2025 as he shares insights and updates on the latest trends and developments in the industry.

52
article thumbnail

IMU-856 Shows Promise in Celiac Disease: Histologic Protection and Nutrient Absorption Key to Advancing Trials

PharmExec

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

52
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Sickle cell gene therapy Casgevy finally cleared for NHS use

pharmaphorum

Vertex's gene-editing therapy for sickle cell disease, Casgevy, has been given the nod for use by the NHS in England after an earlier rejection

52
article thumbnail

FDA Approves Vertex Pharmaceuticals’ First-in-Class Non-Opioid Journavx for Moderate-to-Severe Acute Pain

PharmExec

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

52
article thumbnail

The Rundown on Rebates

Pharmaceutical Commerce

In the final part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Ed Schoonveld value & access advisor for Schoonveld Advisory and author of The Price of Global Health, previews his upcoming February column.

52